No definition available.
Endpoint definition
↥
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
520210 |
1. Apply sex-specific ruleNone |
520210 |
2. Check conditionsNone |
520210 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters:
2 out of 7 registries used, show all original rules. |
150 |
4. Check minimum number of eventsNone |
150 |
5. Include endpointsNone |
150 |
6. Filter based on genotype QC (FinnGen only) |
150 |
Control definitions (FinnGen only)
- Control exclude
- AB1_HELMINTIASES
Extra metadata
- Level in the ICD hierarchy
- 3
- First used in FinnGen datafreeze
- DF5
Enterobiasis
based on the number of shared cases.
Similar with more cases:
Similar with less cases:
Summary Statistics
↥-FinRegistry-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | |||
| Whole population | 2227 | 1452 | 768 |
| Only index persons | 1478 | 977 | 501 |
| Unadjusted period prevalence (%) | |||
| Whole population | 0.03 | 0.04 | 0.02 |
| Only index persons | 0.03 | 0.04 | 0.02 |
| Median age at first event (years) | |||
| Whole population | 7.94 | 7.89 | 7.83 |
| Only index persons | 10.24 | 10.41 | 9.91 |
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 150 | 114 | 36 |
| Unadjusted period prevalence (%) | 0.03 | 0.04 | 0.02 |
| Median age at first event (years) | 30.70 | 27.18 | 41.84 |
-FinRegistry-
Age distribution of first events
-FinnGen-
Age distribution of first events
-FinRegistry-
Year distribution of first events
-FinnGen-
Year distribution of first events
-FinRegistry-
Cumulative Incidence Function
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 139
- Matched controls
- 1390
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
B80
ICD-10 Finland
Enterobiasis
6938.7
169.9
128
*
UJF30
NOMESCO Finland
Ileoscopy through colon
5.4
8.9
27
59
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
3.2
7.1
42
167
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
2.6
6.9
69
379
N77.1*B80
ICD-10 Finland
Vaginitis, vulvitis and vulvovaginitis in pinworm infection
+∞
6.3
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(42870588) Differential panel, method unspecified - Blood
70
398
2.42
6.52
6.5
7.1
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
33
143
2.68
5.33
1.7
1.6
nmol/l
955.2
1111.4
0.60
24
115
(3003327) Ova and parasites identified in Stool by Light microscopy
19
61
3.42
5.12
2.8
1.5
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
29
120
2.76
5.10
1.1
1.2
—
—
—
0
0
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
13
39
3.55
3.86
1.6
1.8
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
75
514
1.92
3.74
5.4
5.7
umol/l
9.3
11.1
1.12
67
482
(3022096) Basophils/100 leukocytes in Blood
80
573
1.85
3.38
7.4
6.8
%
0.7
0.6
0.60
72
535
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
56
360
1.89
3.31
2.5
1.7
pmol/l
86.3
94.0
0.76
32
192
(3006504) Eosinophils/100 leukocytes in Blood
82
596
1.83
3.26
7.3
6.6
%
3.2
2.8
0.82
74
558
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
104
815
1.90
3.24
8.6
6.3
u/l
91.5
82.1
0.74
98
758
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
69
477
1.83
3.22
2.6
2.7
nmol/l
76.5
71.4
0.88
57
430
(3024561) Albumin [Mass/volume] in Serum or Plasma
58
382
1.85
3.15
7.3
5.6
g/l
35.7
36.7
0.68
53
364
(3025941) Bacteria identified in Stool by Culture
15
57
2.81
3.07
1.3
1.3
—
—
—
0
0
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
15
57
2.81
3.07
1.5
1.7
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
37
213
1.98
3.00
2.9
2.2
ug/g
170.8
109.2
0.42
29
160
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
12
41
3.09
2.93
3.0
2.3
—
—
—
0
0
(3028026) IgM [Mass/volume] in Serum or Plasma
17
71
2.57
2.92
1.6
2.1
g/l
1.1
1.4
0.42
17
64
(3019069) Monocytes/100 leukocytes in Blood
81
600
1.76
2.91
7.5
6.9
%
8.4
8.1
0.62
73
568
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
9
23
4.09
2.82
2.1
7.8
—
179.2
—
0
5
(3002030) Lymphocytes/100 leukocytes in Blood
84
633
1.74
2.81
7.4
6.5
%
31.1
31.4
0.11
76
601
(3018010) Neutrophils/100 leukocytes in Blood
83
625
1.73
2.77
6.6
6.3
%
53.9
54.7
0.27
75
595
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
5
6
8.56
2.77
1.0
1.0
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
11
37
3.13
2.75
1.5
1.8
u/ml
181.0
168.9
—
6
18
(3001604) Monocytes [#/volume] in Blood
82
620
1.71
2.66
7.0
6.7
e9/l
0.5
0.6
0.14
70
539
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
63
444
1.72
2.63
7.6
6.6
mmol/l
1.2
1.2
0.10
58
414
(3022145) Colonoscopy Study observation
20
95
2.28
2.63
1.4
1.4
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
22
110
2.17
2.57
1.9
4.2
%
1.7
1.6
0.21
17
104
(3013826) Glucose [Moles/volume] in Serum or Plasma
83
634
1.69
2.56
4.4
4.7
mmol/l
6.5
6.2
0.32
74
560
(3006315) Basophils [#/volume] in Blood
81
620
1.67
2.44
7.3
6.7
e9/l
0.0
0.0
0.46
69
540
(3007164) IgA [Mass/volume] in Serum or Plasma
53
363
1.71
2.42
2.1
1.5
g/l
2.0
2.1
0.14
29
197
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
23
120
2.08
2.42
1.4
3.4
umol/l
7.5
5.4
0.25
18
100
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
19
92
2.22
2.39
2.3
3.1
g/l
0.2
0.2
1.01
19
87
(3044941) Cell count panel - Synovial fluid
5
8
6.42
2.39
1.4
1.6
—
—
—
0
0
(40758558) Short blood count panel - Blood
48
321
1.73
2.38
4.4
7.1
—
—
—
0
0
(3013115) Eosinophils [#/volume] in Blood
83
642
1.66
2.38
7.5
7.2
e9/l
0.2
0.2
0.32
73
562
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
67
491
1.66
2.37
9.0
7.3
mmol/l
1.2
1.2
0.47
56
428
(3019198) Lymphocytes [#/volume] in Blood
84
655
1.64
2.31
7.0
6.5
e9/l
2.0
2.1
0.77
75
581
(3001122) Ferritin [Mass/volume] in Serum or Plasma
81
627
1.63
2.28
4.5
2.8
ug/l
78.2
63.8
0.41
74
582
(3026782) Osmolality of Urine
36
225
1.79
2.24
2.5
2.6
mosm/kgh2o
525.5
558.3
0.32
31
182
(3021589) Normoblasts [#/volume] in Blood
74
564
1.62
2.19
9.2
8.6
e9/l
0.0
0.0
0.50
65
450
(3013650) Neutrophils [#/volume] in Blood by Automated count
90
721
1.62
2.16
8.7
9.1
e9/l
4.0
4.1
0.10
78
627
(3000494) Fungus identified in Specimen by Culture
23
127
1.96
2.08
1.4
1.3
—
—
—
0
0
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
20
105
2.04
2.07
1.6
1.7
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
11
44
2.62
2.06
1.3
1.2
—
—
—
0
0
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
44
298
1.67
2.06
3.9
2.0
mg/l
3.2
2.8
0.58
38
255
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
5
11
4.66
1.95
1.2
1.5
—
—
—
0
0
(3013512) EKG study
36
237
1.68
1.86
3.5
3.3
—
—
—
0
0
(3013707) Erythrocyte sedimentation rate by Westergren method
103
873
1.57
1.78
4.7
3.8
mm/h
9.6
9.5
0.02
95
801
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
54
400
1.55
1.72
1.9
1.5
u/ml
3.5
1.8
—
10
95
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
10
42
2.48
1.71
1.2
1.2
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
26
160
1.76
1.70
1.2
1.2
—
—
—
0
0
(3048929) Epstein Barr virus Ab [Presence] in Serum
17
91
1.98
1.68
1.6
1.5
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
116
1017
1.62
1.68
13.2
9.0
ml/min/173m2
97.5
94.9
0.52
94
783
(3037467) Urinalysis macro (dipstick) panel - Urine
100
848
1.54
1.68
4.6
4.3
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
10
43
2.42
1.64
1.2
1.2
—
—
—
0
0
(3023368) Bacteria identified in Blood by Culture
34
228
1.64
1.63
4.0
4.1
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
137
1261
2.00
1.60
11.6
8.4
u/l
26.8
24.0
0.70
132
1213
(3016650) Hepatitis A virus Ab [Presence] in Serum
6
20
3.08
1.60
1.2
1.0
—
—
—
0
0
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
6
20
3.08
1.60
1.5
1.5
—
—
—
0
0
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
39
273
1.58
1.57
2.7
2.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
10
44
2.36
1.57
1.2
1.2
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
19
109
1.85
1.55
3.7
3.6
%
30.4
31.7
0.22
11
69
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
135
1240
1.89
1.54
16.1
11.1
mg/l
16.7
21.7
1.20
105
920
(3034770) Mitochondria Ab [Titer] in Serum
7
27
2.67
1.53
1.3
1.3
—
—
—
0
0
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
9
37
2.52
1.51
1.7
1.6
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
26
166
1.68
1.50
1.4
1.7
pmol/l
396.0
44371298.2
0.50
20
151
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
10
45
2.31
1.50
1.1
1.4
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
13
66
2.06
1.48
1.5
2.0
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
9
38
2.45
1.48
1.7
1.6
—
—
—
0
0
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
7
28
2.57
1.47
1.1
1.3
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
6
22
2.80
1.45
1.3
2.1
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
32
218
1.59
1.44
1.9
1.6
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
7
29
2.48
1.41
1.3
2.0
—
—
—
0
0
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
6
23
2.67
1.38
3.0
2.8
—
—
—
0
0
(3019225) pH of Specimen
15
83
1.90
1.37
6.7
4.5
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
9
42
2.21
1.36
1.9
1.5
—
—
—
0
0
(3032080) INR in Blood by Coagulation assay
43
318
1.49
1.35
4.6
7.5
inr
1.0
1.2
2.02
15
94
(3000850) Epithelial cells [#/volume] in Urine
34
239
1.55
1.34
2.7
2.6
e6/l
5.0
7.3
0.53
28
205
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
49
373
1.47
1.33
2.0
1.8
—
—
—
0
0
(3000991) Gas panel - Venous blood
18
107
1.78
1.33
6.4
9.0
—
—
—
0
0
(3018418) pH of Serum or Plasma
38
275
1.51
1.32
7.7
3.2
ph
7.4
7.4
—
10
43
(3020779) Urea [Moles/volume] in Serum or Plasma
14
77
1.90
1.30
8.9
10.5
mmol/l
9.2
6.6
0.67
14
77
(3003694) ABO and Rh group [Type] in Blood
57
449
1.43
1.29
2.0
1.8
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
56
440
1.44
1.28
1.9
1.8
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
13
70
1.94
1.28
5.9
5.6
%
0.0
0.1
—
7
22
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
121
1095
1.54
1.28
4.8
3.9
—
—
—
0
0
(3009542) Hematocrit [Volume Fraction] of Blood
132
1223
1.66
1.20
13.2
12.2
%
40.0
39.8
0.08
103
995
(3029287) Urinalysis microscopic panel [#/volume] - Urine by Automated count
50
389
1.43
1.20
3.8
3.6
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
48
371
1.43
1.19
2.7
2.5
—
—
—
0
0
(3012544) pH of Venous blood
20
127
1.66
1.19
5.8
6.9
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
8
40
2.06
1.14
3.0
2.4
—
—
—
0
0
(3044640) Blood type and Crossmatch panel - Blood
46
357
1.42
1.11
2.5
2.1
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
25
172
1.54
1.09
1.4
1.4
titre
384.0
598.9
—
5
35
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
69
577
1.36
1.06
4.3
4.0
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
22
148
1.57
1.05
6.2
2.1
mmol/l
2.4
2.4
0.06
17
132
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
5
22
2.31
1.04
1.4
1.8
—
—
—
0
0
(3017181) Myelocytes/100 leukocytes in Blood
13
76
1.78
1.02
5.9
5.4
%
1.3
0.5
—
7
25
(3018095) Leukocytes [#/volume] in Urine
53
427
1.37
1.02
4.5
4.0
e6/l
61.1
51.7
0.08
35
289
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
14
84
1.74
1.02
2.9
3.1
—
—
—
0
0
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
7
35
2.05
1.01
1.6
1.9
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
7
35
2.05
1.01
1.0
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
109
984
1.39
1.01
5.1
4.1
pmol/l
14.7
14.4
0.54
101
899
(3030467) Casts [#/volume] in Urine by Automated count
41
319
1.39
0.97
4.0
3.5
e6/l
0.3
0.2
0.31
31
242
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
23
161
1.51
0.93
1.9
1.9
—
—
—
0
0
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
39
303
1.39
0.93
3.1
3.3
ng/l
12.6
28.2
1.01
17
158
(3001019) Free T4 and TSH panel - Serum or Plasma
12
71
1.75
0.92
2.1
1.5
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
12
71
1.75
0.92
1.2
1.1
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
44
350
1.36
0.91
4.0
3.5
e6/l
41.9
40.5
0.02
35
274
(3011288) Drugs identified in Urine by Screen method
14
87
1.67
0.91
2.1
2.3
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
6
29
2.11
0.90
1.3
1.9
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
8
42
1.95
0.90
2.4
1.8
u/l
37.8
36.9
—
8
37
(3015377) Calcium [Moles/volume] in Serum or Plasma
44
352
1.35
0.88
4.5
2.8
mmol/l
2.3
2.4
0.56
37
317
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
14
88
1.65
0.88
7.0
7.0
mmol/l
24.9
23.9
0.82
14
83
(40768443) Skin Pathology biopsy report
8
47
1.74
0.82
1.3
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
30
228
1.39
0.81
2.5
3.0
umol/l
329.7
3379.2
0.80
24
203
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
19
132
1.50
0.81
3.8
2.6
u/l
221.1
3762.0
—
8
54
(36304419) Bacteria [Presence] in Urine
40
320
1.34
0.80
4.0
3.4
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
6
34
1.80
0.77
1.5
1.4
—
—
—
0
0
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
90
807
1.29
0.77
3.7
3.0
u/l
43.5
36.1
0.51
84
770
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
9
54
1.71
0.76
2.2
1.5
—
—
—
0
0
(3021960) Folate [Moles/volume] in Serum or Plasma
29
223
1.37
0.74
1.3
1.4
nmol/l
16.9
21.5
1.17
23
192
(3007853) Bacteria identified in Skin by Aerobe culture
20
144
1.45
0.72
1.7
1.5
—
—
—
0
0
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
13
85
1.58
0.71
3.2
6.1
mmol/l
1.4
1.3
—
6
61
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
122
1145
1.35
0.70
5.8
4.7
mu/l
1.7
1.9
0.73
114
1067
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
42
1.70
0.69
1.3
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
32
253
1.34
0.69
1.5
2.4
mg/l
0.9
1.0
0.18
16
187
(3012516) Albumin [Mass/volume] in Urine
27
210
1.35
0.65
3.6
3.3
mg/l
69.2
120.6
0.45
20
137
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
6
103
0.57
0.64
1.2
1.5
—
—
—
0
0
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
0
21
0.00
0.60
0.0
2.4
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
10
64
1.60
0.60
1.2
3.7
mmol/l
1.2
1.2
—
10
54
(3042936) Bacteria identified in Isolate by Culture
19
141
1.40
0.60
1.9
1.8
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
0
22
0.00
0.60
0.0
1.0
—
0.0
—
0
22
(3029379) Protein.monoclonal band 4 [Mass/volume] in Serum or Plasma by Electrophoresis
0
22
0.00
0.60
0.0
1.0
—
0.0
—
0
22
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
0
23
0.00
0.59
0.0
1.0
—
0.0
—
0
23
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
0
23
0.00
0.59
0.0
1.0
—
39.1
—
0
23
(3026008) Bacteria identified in Urine by Culture
44
373
1.25
0.57
2.8
2.7
—
—
—
0
0
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
6
37
1.65
0.56
3.2
2.2
—
—
—
0
0
(1761868) Lipid panel - Serum or Plasma
33
397
0.78
0.56
2.4
2.3
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
15
108
1.43
0.55
1.1
1.0
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
41
346
1.25
0.55
2.7
2.3
—
—
—
0
0
(3044889) 12 lead EKG panel
74
666
1.22
0.55
2.6
2.9
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
100
1064
0.82
0.50
3.7
3.4
mmol/l
1.5
1.5
0.13
92
998
(3042206) Streptococcus agalactiae Ag [Presence] in Vaginal fluid
7
45
1.58
0.49
1.0
1.1
—
—
—
0
0
(3022313) Gas panel - Capillary blood
11
76
1.48
0.49
3.5
5.7
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
7
46
1.55
0.49
1.0
1.2
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
15
111
1.39
0.49
1.5
1.6
—
—
—
0
0
(3021879) Hepatitis B virus core Ab [Presence] in Serum
17
129
1.36
0.48
1.9
1.6
—
—
—
0
0
(40761511) CBC panel - Blood by Automated count
135
1303
1.36
0.48
13.2
9.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
53
467
1.21
0.47
2.6
2.2
—
—
—
0
0
(3002385) Erythrocyte distribution width [Ratio]
117
1111
1.24
0.47
15.7
13.8
%
13.4
13.3
0.39
117
1095
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
7
49
1.45
0.46
1.7
1.7
—
—
—
0
0
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
101
1068
0.83
0.43
3.6
3.5
mmol/l
4.6
4.6
0.33
94
1004
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
15
114
1.35
0.42
1.5
1.7
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
0
15
0.00
0.41
0.0
2.3
—
22.0
—
0
9
(4094501)
0
17
0.00
0.41
0.0
1.0
—
—
—
0
0
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
0
17
0.00
0.41
0.0
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
14
106
1.35
0.41
1.6
1.4
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
14
106
1.35
0.41
1.6
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
14
106
1.35
0.41
1.6
1.4
—
—
—
0
0
(3020682) Albumin/Creatinine [Ratio] in Urine
26
216
1.25
0.40
4.5
3.9
mg/mmol
8.9
16.9
0.52
21
141
(3025159) Blasts/100 leukocytes in Blood
10
71
1.44
0.40
6.5
5.4
%
0.2
0.0
—
5
20
(3038515) Glucose [Moles/volume] in Venous blood
0
18
0.00
0.40
0.0
2.9
—
7.7
—
0
18
(40768804) Tissue Pathology biopsy report
48
426
1.19
0.39
1.8
1.8
—
—
—
0
0
(3008037) Lactate [Moles/volume] in Venous blood
0
19
0.00
0.39
0.0
2.8
—
1.3
—
0
19
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
14
107
1.34
0.39
1.6
1.4
—
—
—
0
0
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
13
99
1.34
0.37
9.0
6.5
—
—
—
0
0
(3041096) Erythrocytes [Presence] in Urine by Automated
31
357
0.83
0.35
2.9
2.9
—
—
—
0
0
(3015736) pH of Urine
54
490
1.16
0.34
2.7
3.3
—
—
—
0
0
(3002256) Pathology report gross observation
15
119
1.29
0.33
1.2
1.1
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
97
1019
0.86
0.33
3.4
3.2
mmol/l
1.3
1.2
0.24
88
950
(3023511) Choriogonadotropin [Units/volume] in Urine
12
92
1.33
0.33
1.3
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
13
103
1.29
0.29
4.5
3.0
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
13
103
1.29
0.29
1.8
1.8
—
—
—
0
0
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
103
1073
0.87
0.28
3.8
3.7
mmol/l
2.7
2.8
0.41
94
1002
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
35
313
1.15
0.26
1.5
1.5
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
14
114
1.25
0.26
1.8
1.7
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
37
334
1.14
0.24
2.1
1.7
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
5
42
1.20
0.21
4.6
1.2
—
—
—
0
0
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3001684) Respiratory syncytial virus Ag [Presence] in Specimen
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
0
10
0.00
0.21
0.0
1.8
—
—
—
0
0
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
14
117
1.22
0.21
1.6
1.5
—
—
—
0
0
(4027681)
0
13
0.00
0.21
0.0
1.3
—
—
—
0
0
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
0
13
0.00
0.21
0.0
1.5
—
—
—
0
0
(3035285) Chloride [Moles/volume] in Venous blood
0
13
0.00
0.21
0.0
3.1
—
105.5
—
0
13
(3041354) Potassium [Moles/volume] in Venous blood
0
13
0.00
0.21
0.0
3.1
—
4.0
—
0
13
(3033705) Calcium.ionized [Moles/volume] in Venous blood
0
13
0.00
0.21
0.0
3.1
—
—
—
0
0
(3000093) Morphology [Interpretation] in Blood Narrative
0
13
0.00
0.21
0.0
1.4
—
—
—
0
0
(3024891) Influenza virus A+B Ag [Presence] in Specimen
6
48
1.26
0.20
1.0
1.2
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
11
133
0.81
0.20
1.2
1.7
—
—
—
0
0
(3039443) Prostate specific Ag panel - Serum or Plasma
0
14
0.00
0.20
0.0
1.6
—
—
—
0
0
(3007368) IgG [Mass/volume] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
36.6
—
0
8
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
14
0.00
0.20
0.0
1.4
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
27
242
1.14
0.20
2.3
2.0
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
6
52
1.16
0.19
1.2
1.5
—
—
—
0
0
(4035726)
5
65
0.76
0.17
1.2
1.3
—
—
—
0
0
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
44
470
0.91
0.17
2.7
3.3
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
7
88
0.79
0.15
1.3
1.7
—
—
—
0
0
(3003338) MCHC [Mass/volume]
114
1162
0.92
0.12
16.5
14.4
g/l
331.0
333.2
1.40
114
1154
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
23
211
1.11
0.12
1.3
1.2
u/ml
0.9
7.5
—
5
82
(3027008) Opiates [Presence] in Urine
14
124
1.14
0.11
1.8
1.7
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
14
124
1.14
0.11
2.0
1.7
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
17
153
1.13
0.11
2.3
2.1
—
—
—
0
0
(21494755) Public health laboratory ask at order entry panel
13
146
0.88
0.11
1.2
1.3
—
—
—
0
0
(3028300) Cannabinoids [Presence] in Urine
14
125
1.13
0.10
1.8
1.7
—
—
—
0
0
(3004716) Salmonella sp identified in Stool by Organism specific culture
12
106
1.14
0.10
1.5
1.4
—
—
—
0
0
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
5
48
1.04
0.09
1.4
1.5
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
11
97
1.14
0.09
6.3
7.6
mmol/l
104.5
103.8
0.21
11
91
(3002173) Hemoglobin [Mass/volume] in Arterial blood
6
70
0.85
0.08
5.7
8.2
g/l
120.8
123.5
—
6
65
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
10
112
0.89
0.07
3.9
4.1
%
28.7
21.5
—
5
46
(40761535) Cells panel - Urine sediment
8
78
1.03
0.07
2.0
3.8
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
7
83
0.84
0.07
3.3
2.2
nmol/l
10.3
12.8
—
7
75
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
9
87
1.04
0.07
4.4
7.2
kpa
5.7
5.2
—
9
82
(3027801) Oxygen [Partial pressure] in Arterial blood
9
87
1.04
0.07
4.4
7.2
kpa
9.1
12.8
—
9
82
(3047352) Trisomy 18 risk [Likelihood] in Fetus
9
88
1.02
0.07
1.7
1.4
—
—
—
0
0
(3005033) Fetal Nuchal fold Thickness US
9
88
1.02
0.07
1.7
1.4
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
106
1044
1.05
0.07
3.9
3.4
mmol/l
5.6
5.6
0.06
94
958
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
94
924
1.05
0.06
5.2
4.2
mmol/mol
37.3
37.7
0.13
83
861
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
27
257
1.06
0.06
1.3
1.7
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
19
201
0.94
0.05
4.6
3.2
e6/l
0.7
0.6
—
9
123
(3009261) Glucose [Presence] in Urine by Test strip
60
611
0.97
0.03
3.1
3.5
estimate
0.0
0.0
0.00
14
109
(3029937) Albumin [Presence] in Urine by Test strip
31
320
0.96
0.03
3.1
3.5
estimate
0.0
0.0
0.00
13
109
(3043238) Trisomy 21 risk [Likelihood] in Fetus
10
92
1.09
0.03
1.7
1.5
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
28
288
0.97
0.02
3.2
3.5
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
20
193
1.04
0.01
1.8
1.8
—
—
—
0
0
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
18
176
1.03
0.00
3.6
2.5
ng/l
14.1
412.5
1.91
12
102
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
19
191
0.99
0.00
4.6
3.3
e6/l
1.7
3.1
—
7
114
(3021601) Nitrite [Presence] in Urine by Test strip
60
602
0.99
0.00
4.5
4.9
estimate
0.0
0.0
0.00
14
112
(3027944) Amphetamines [Presence] in Urine
12
123
0.97
0.00
2.1
1.7
—
—
—
0
0
(40760892) CBC W Ordered Manual Differential panel - Blood
30
295
1.02
0.00
6.7
4.9
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
13
132
0.98
0.00
1.6
1.3
—
—
—
0
0
(3000492) Spirometry study
10
95
1.06
0.00
1.6
1.4
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
20
202
0.99
0.00
1.6
1.5
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
5.8
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
0
8
0.00
0.00
0.0
1.3
—
—
—
0
0
(3005791) Eosinophil cationic protein (ECP) [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.8
—
17.0
—
0
5
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
0
5
0.00
0.00
0.0
1.2
—
263.6
—
0
5
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
6.6
—
191.6
—
0
5
(3036071) Salmonella sp Ab [Titer] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3011831) Apolipoprotein B/Apolipoprotein A-I [Percentile]
0
8
0.00
0.00
0.0
1.6
—
—
—
0
0
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3029075) Extractable nuclear Ab panel - Serum
0
8
0.00
0.00
0.0
1.0
—
—
—
0
0
(37021550) Renin [Units/volume] in Plasma --upright
0
5
0.00
0.00
0.0
1.6
—
149.9
—
0
5
(3043410) Blood group antigens tested for on Red Blood Cells
0
5
0.00
0.00
0.0
1.4
—
—
—
0
0
(3017817) Protein [Mass] in Urine collected for unspecified duration
0
5
0.00
0.00
0.0
2.4
—
—
—
0
0
(3030136) 5-Hydroxyindoleacetate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
3.8
—
43.6
—
0
5
(3051611) Lipemic interference index of Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
—
—
0
0
(44816808) CXCL13 Ag [Mass/volume] in Cerebral spinal fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.6
—
—
—
0
0
(3019420) Tryptase [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
2.3
—
8.5
—
0
6
(3016845) Adenovirus Ag [Presence] in Specimen by Immunofluorescence
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
0
7
0.00
0.00
0.0
2.6
—
—
—
0
0
(4146454)
0
6
0.00
0.00
0.0
4.2
—
—
—
0
0
(3011436) Histone Ab [Units/volume] in Serum
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
0
9
0.00
0.00
0.0
1.2
—
—
—
0
0
(3028433) Virus identified in Specimen by Culture
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
5
57
0.87
0.00
1.4
1.3
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
1.0
—
0
9
(3044242) Glucose [Moles/volume] in Arterial blood
0
7
0.00
0.00
0.0
1.9
—
—
—
0
0
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3045066) Thymidine kinase [Enzymatic activity/volume] in Serum
0
7
0.00
0.00
0.0
1.3
—
35.7
—
0
7
(3035350) Ketones [Presence] in Urine by Test strip
61
610
1.00
0.00
3.1
3.4
estimate
0.0
0.0
0.00
13
109
(3037692) Legionella sp identified in Specimen by Organism specific culture
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(3008364) Apolipoprotein A-I [Mass/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.6
—
—
—
0
0
(3036782) Glucose [Moles/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.2
—
7.1
—
0
6
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
0
7
0.00
0.00
0.0
1.4
—
—
—
0
0
(3005011) Chlamydia sp Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3051651) Icteric interference index of Serum or Plasma
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(4010399)
8
81
0.99
0.00
1.1
1.3
—
—
—
0
0
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
(3003434) Protein [Mass/volume] in Pleural fluid
0
6
0.00
0.00
0.0
1.5
—
35.8
—
0
6
(3008898) HLA-B27 [Presence]
8
82
0.97
0.00
1.0
1.1
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3026048) Bordetella pertussis IgG Ab [Units/volume] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(40768806) Pleura Pathology biopsy report
0
7
0.00
0.00
0.0
1.6
—
—
—
0
0
(40758990) Choriogonadotropin.beta subunit [Mass/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3045209) Lutropin/Follitropin [Ratio] in Serum or Plasma
0
7
0.00
0.00
0.0
1.1
—
—
—
0
0
(3034426) Prothrombin time (PT)
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(3013336) Amino acids [Identifier] in Serum or Plasma
0
6
0.00
0.00
0.0
4.3
—
—
—
0
0
(4024509)
0
7
0.00
0.00
0.0
1.3
—
—
—
0
0
(4281824)
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3020321) Streptococcus agalactiae [Presence] in Vaginal fluid by Organism specific culture
9
93
0.97
0.00
1.9
1.6
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
7
0.00
0.00
0.0
2.4
—
15.2
—
0
7
(3007821) Glucose [Moles/volume] in Serum or Plasma --baseline
0
6
0.00
0.00
0.0
1.3
—
5.6
—
0
6
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
0
9
0.00
0.00
0.0
1.1
—
—
—
0
0
(40760847) Basement membrane Ab [Titer] in Serum by Immunofluorescence
0
6
0.00
0.00
0.0
1.2
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
0
6
0.00
0.00
0.0
4.8
—
—
—
0
0
Mortality – FinRegistry
↥Association
Association between endpoint AB1_ENTEROBIASIS and mortality.
Females
No dataMales
No dataMortality risk
Mortality risk for people of age
years, who have AB1_ENTEROBIASIS.| N-year risk | Females | Males |
|---|---|---|
| 1 | No data | No data |
| 5 | No data | No data |
| 10 | No data | No data |
| 15 | No data | No data |
| 20 | No data | No data |
Relationships between endpoints
↥Index endpoint: AB1_ENTEROBIASIS – Enterobiasis
GWS hits: 1
Endpoint
Case Overlap
Survival Analysis
Genetic Correlations
Genetic Signals
N (Jaccard index)
HR [CI]
rg [CI]
Hits
Coloc Hits
FinRegistry
FinnGen
FinRegistry
FinnGen
FinnGen
Loading data